CLINICAL_TRIALS
research
· 2025-03-28
Clinical Trial Update: Targeting Endoplasmic Reticulum Stress in Human Hypertension [Phase 1, Phase 2]
Summary
An ongoing Phase 1/2 clinical trial is evaluating targeting endoplasmic reticulum stress as a treatment for hypertension. The study is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of North Texas Health Science Center | Conditions: Hypertension | Phase 1, Phase 2 | Status: RECRUITING